Clinical Trials Browser

Breast Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

HER2 Negative Breast Cancer

Breast Neoplasms

Endometrial Neoplasms

Carcinoma, Intraductal, Noninfiltrating

Advanced Breast Cancer

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

Advanced Breast Carcinoma

Low Grade Serous Ovarian Carcinoma

Recurrence, Endometrial Neoplasms

Estrogen Receptor-positive Breast Cancer

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Low-Grade Serous Ovarian Cancer

Carcinoma, Non-Small-Cell Lung

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Locoregional Recurrence

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Female

Clinical Trials

A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

NAOMI

FASCINATE-N

CAMERAN

SELECT

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

A Study of Lerociclib in Participants With Advanced Breast Cancer

OMAHA-015

I-SPY

PF-07104091 as a Single Agent and in Combination Therapy

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

ALEPRO

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

CHAMELEON

KAT6

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

RaPhLRR

LaPemERLA

ADEPT

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

NeoMARS

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer